XPH
SPDR S&P Pharmaceuticals ETF

XPH$48.69
$-0.16
(-0.33%)
As of 8:00:00 PM EDT | 9/21/18  |  Market Closed

XPH Trading Data

Open

$48.95

Low Price

$48.62

High Price

$48.98

Previous Last Price

$48.85

Bid Size

$0 X 0

Ask Size

$0 X 0

XPH Portfolio Data

AUM

$400,580

Shares

8,200

PE Ratio

10.08

Price / Book Ratio

1.96

Expense Ratio

0.35

Net Asset Value

$48.85

Volume

Volume

37,200

Avg. Volume (YDT)

82,201

Dollar Volume

$1,649,931

Weekly Avg. Volume

80,360

Monthly Avg. Volume

87,390

Quarterly Avg. Volume

80,952

XPH Fund Description

The SPDR SP Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Pharmaceuticals Select Industry Index.

XPH Chart

XPH Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Pharmaceuticals ETF

Inception Date

2006-06-19

Asset Class

Equity

Asset Class Size

Biotech

XPH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XPH Holdings

Top 10 Holdings

Mallinckrodt Plc (MNK)
6.04%
Eli Lilly and Company (LLY)
5.04%
Pfizer Inc. (PFE)
4.84%
Endo International Plc (ENDP)
4.82%
Bristol-Myers Squibb Company (BMY)
4.69%
Johnson & Johnson (JNJ)
4.64%
Merck & Co. Inc. (MRK)
4.59%
Allergan plc (AGN)
4.53%
Nektar Therapeutics (NKTR)
4.3%
Zoetis Inc. Class A (ZTS)
4.21%

Total XPH Holdings

Total Holdings: 47

Mallinckrodt Plc (MNK)
6.04%
Eli Lilly and Company (LLY)
5.04%
Pfizer Inc. (PFE)
4.84%
Endo International Plc (ENDP)
4.82%
Bristol-Myers Squibb Company (BMY)
4.69%
Johnson & Johnson (JNJ)
4.64%
Merck & Co. Inc. (MRK)
4.59%
Allergan plc (AGN)
4.53%
Nektar Therapeutics (NKTR)
4.3%
Zoetis Inc. Class A (ZTS)
4.21%
Perrigo Co. Plc (PRGO)
4.11%
Mylan N.V. (MYL)
3.79%
Jazz Pharmaceuticals Plc (JAZZ)
3.78%
Pacira Pharmaceuticals Inc. (PCRX)
3.27%
Catalent Inc (CTLT)
2.93%
Horizon Pharma plc (HZNP)
2.68%
Prestige Consumer Healthcare Inc (PBH)
2.55%
Supernus Pharmaceuticals Inc. (SUPN)
2.52%
Akorn Inc. (AKRX)
2.29%
Medicines Company (MDCO)
2.16%
Endocyte Inc. (ECYT)
1.98%
Amneal Pharmaceuticals Inc. Class A (AMRX)
1.97%
Zogenix Inc. (ZGNX)
1.83%
MyoKardia Inc. (MYOK)
1.82%
Omeros Corporation (OMER)
1.48%
Corcept Therapeutics Incorporated. (CORT)
1.4%
Innoviva Inc. (INVA)
1.21%
Aerie Pharmaceuticals Inc. (AERI)
1.14%
Reata Pharmaceuticals Inc. Class A (RETA)
1.1%
CymaBay Therapeutics Inc. (CBAY)
0.89%
TherapeuticsMD Inc. (TXMD)
0.89%
Intra-Cellular Therapies Inc. (ITCI)
0.67%
Theravance Biopharma Inc (TBPH)
0.64%
Revance Therapeutics Inc. (RVNC)
0.6%
Assertio Therapeutics Inc. (ASRT)
0.59%
Intersect ENT Inc (XENT)
0.57%
Wave Life Sciences Ltd. (WVE)
0.56%
Collegium Pharmaceutical Inc. (COLL)
0.53%
Assembly Biosciences Inc. (ASMB)
0.52%
ANI Pharmaceuticals Inc. (ANIP)
0.39%
Amphastar Pharmaceuticals Inc (AMPH)
0.33%
Phibro Animal Health Corporation Class A (PAHC)
0.33%
Aclaris Therapeutics Inc. (ACRS)
0.31%
Lannett Company Inc. (LCI)
0.26%
STATE STREET INSTL US GOVERNME OPEN-END (Unassigned)
0.21%
SPDR S & P Pharmaceuticals ETF (XPH)
0%
U.S. Dollar
0%

XPH Technicals

Alpha

-16.93

Beta

1.92

Leverage

Long

Standard Deviation

1.48

XPH Dividends

Dividend Date

2018-06-15

Latest Dividend

0.059

Annual Dividend

0.26

Annual Dividend Rate

0.26

Annual Dividend Yield

0.53

XPH Performance

YTD Return

11.93%

1 Year Return

14.94%

3 Year Return

-2.91%

5 Year Return

26.29%

10 Year Return

210.72%

XPH Related Articles

Pharmaceutical ETFs Could Maintain Their Momentum

Pharmaceutical ETFs Could Maintain Their Momentum

Pharmaceutical stocks and sector-related exchange traded funds have enjoyed a great summer and the rally may continue to have legs. Over the past three months, the PowerShares Dynamic Pharmaceuticals Portfolio…

July Could Be a Volatile Month for Pharma ETFs

July Could Be a Volatile Month for Pharma ETFs

Changing political winds and the seasonal period for drugmakers to hike their prices could trigger short-term volatility in pharmaceutical sector-related ETFs. The markets could put a spotlight on pharmaceutical stocks…

Get Lucky With 10 Saint Patrick’s Day ETFs

Get Lucky With 10 Saint Patrick’s Day ETFs

Well folks, it’s that special time of the year on Saturday: the green revolution, the grand day of Guinness, the celebration of corn beef hash, and of course – Saint Patrick’s…

Pharmaceutical ETF Surges on Healthy Outlook

Pharmaceutical ETF Surges on Healthy Outlook

Investors looking to play a rebound in pharmaceuticals stocks have an array of exchange traded funds to consider. The SPDR Pharmaceuticals ETF (NYSEArca: XPH) is an equal-weight approach to pharmaceuticals…

Why Healthcare Sector is a Great November Play

Why Healthcare Sector is a Great November Play

It is already the second-best sector this year behind technology, but the healthcare sector has a penchant for performing well in November. On historical basis, healthcare’s November bullishness includes biotechnology…

Drug Makers, Pharma ETFs Face a Tough Earnings Season

Drug Makers, Pharma ETFs Face a Tough Earnings Season

The healthcare sector has been lackluster this earnings season, and without supporting factors such as price increases or increased mergers and acquisitions to bolster the segment, pharmaceutical exchange traded funds…